Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divergent-paired related homeobox pseudogene 1 (DPRXP1) is annotated as a pseudogene and does not code for a functional protein or transcript[5]. Pseudogenes are segments of DNA that resemble known genes but are generally nonfunctional due to mutations or lack of regulatory elements. There are no reported biological activities, molecular interactions, disease associations, or therapeutic implications for DPRXP1. Be aware that "DPRXP1" is sometimes confused with "DPRX" (divergent-paired related homeobox), which is an actual protein-coding gene involved in embryonic development[7]; however, DPRXP1 is not equivalent and should not be used as a therapeutic target designation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divergent-paired related homeobox pseudogene 1 (DPRXP1).